Trimeris.

PositionTriangle - Roche Holding Ltd. - Brief Article

DURHAM -- Trimeris says Switzerland-based Roche will be able to produce enough of Trimeris' new AIDs drug Fuzeon (cover, July) by the end of the year to treat 18,000 patients--about 20% more than it initially expected. Trimeris...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT